Onderneming Conduit Pharmaceuticals Inc.
Aandelen
CDT
US20678X1063
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
2,84 USD | +1,07% | -6,58% | -37,58% |
Vakgebied
Aantal werknemers: 7
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Adam Sragovicz
DFI | Director of Finance/CFO | 55 | 01-10-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Freda Lewis-Hall
CHM | Chairman | 69 | 22-09-23 |
Director/Board Member | 50 | 22-09-23 | |
Faith Charles
BRD | Director/Board Member | 62 | 22-09-23 |
Andrew Regan
BRD | Director/Board Member | 59 | 22-09-23 |
David Tapolczay
CEO | Chief Executive Officer | 64 | 22-09-23 |
Chele Farley
BRD | Director/Board Member | 56 | 22-09-23 |
James Bligh
BRD | Director/Board Member | 36 | 22-09-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 73 829 536 | 9 928 091 ( 13,45 %) | 0 | 13,45 % |
Bedrijfsgegevens
Conduit Pharmaceuticals, Inc.
4995 Murphy Canyon Road Suite 300
92123, San Diego
+
http://www.conduitpharma.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-37,58% | 210 mln. | |
+51,85% | 57,87 mld. | |
+41,42% | 40,25 mld. | |
-5,25% | 39,94 mld. | |
-5,16% | 28,54 mld. | |
+12,79% | 26,4 mld. | |
-20,18% | 19,33 mld. | |
+30,88% | 12,4 mld. | |
+0,61% | 12,23 mld. | |
+25,06% | 12,2 mld. |